The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Antimicrobial Characterization of Human β-Defensin 3 Derivatives
Open accessAbstract
Human β-defensin 3 (hBD3) is a highly basic 45-amino-acid protein that acts both as an antimicrobial agent and as a chemoattractant molecule. Although the nature of its antimicrobial activity is largely electrostatic, the importance of the molecular structure on this activity is poorly understood. Two isoforms of hBD3 were synthesized: the first with native disulfide linkages and the second with nonnative linkages. In a third synthetic peptide, all cysteine residues were replaced with α-aminobutyric acid, creating a completely linear peptide. A series of six small, linear peptides corresponding to regions of hBD3 with net charges ranging from +4 to +8 (at pH 7) and lengths ranging from 9 to 20 amino acids were also synthesized. The linear full-length peptide showed the highest microbicidal activity against Escherichia coli and Staphylococcus aureus, while all three full-length forms showed equal activity against Candida albicans. The linear peptide also showed high activity against Enterococcus faecium and Pseudomonas aeruginosa.Peptides corresponding to the C terminus showed higher activities when tested against E. coli, with the most active peptides being the most basic. However, only the peptide corresponding to the N terminus of hBD3 showed any activity against S. aureus and C. albicans. Further, N-terminal deletion mutants of native hBD3 showed diminished activities against S. aureus. Thus, the antimicrobial properties of hBD3 derivatives are determined by both charge and structure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Defensins. Natural peptide antibiotics of human neutrophils.
Ganz, T., Selsted, M. E., Szklarek, D., Harwig, S. S., Daher, K., Bainton, D. F., & Lehrer, R. I. (1985) · Journal of Clinical Investigation · doi:10.1172/jci112120 · Cited by 1,416
A peptide antibiotic from human skin
Harder, J., Bartels, J., Christophers, E., & Schröder, J.-M. (1997) · Nature · doi:10.1038/43088 · Cited by 1,363
Isolation and Characterization of Human μ-Defensin-3, a Novel Human Inducible Peptide Antibiotic
Harder, J., Bartels, J., Christophers, E., & Schröder, J.-M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008557200 · Cited by 1,311
SCHNölzer, M., ALEWOOD, P., JONES, A., ALEWOOD, D., & KENT, S. B. H. (1992) · International Journal of Peptide and Protein Research · doi:10.1111/j.1399-3011.1992.tb00291.x · Cited by 1,049
Peschel, A., Otto, M., Jack, R. W., Kalbacher, H., Jung, G., & Götz, F. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.13.8405 · Cited by 994
Tang, Y.-Q., Yuan, J., Ösapay, G., Ösapay, K., Tran, D., Miller, C. J., Ouellette, A. J., & Selsted, M. E. (1999) · Science · doi:10.1126/science.286.5439.498 · Cited by 700
hBD‐1: a novel β‐defensin from human plasma
Bensch, K. W., Raida, M., Mägert, H.-J., Schulz-Knappe, P., & Forssmann, W.-G. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)00687-5 · Cited by 545
Kagan, B. L., Selsted, M. E., Ganz, T., & Lehrer, R. I. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.1.210 · Cited by 532
Crystal Structure of Defensin HNP-3, an Amphiphilic Dimer: Mechanisms of Membrane Permeabilization
Hill, C. P., Yee, J., Selsted, M. E., & Eisenberg, D. (1991) · Science · doi:10.1126/science.2006422 · Cited by 507
García, J.-R. C., Krause, A., Schulz, S., Rodríguez-Jiménez, F.-J., Klüver, E., Adermann, K., Forssmann, U., Frimpong-Boateng, A., Bals, R., & Forssmann, W.-G. (2001) · The FASEB Journal · doi:10.1096/fj.00-0865fje · Cited by 470
Wu, Z., Hoover, D. M., Yang, D., Boulègue, C., Santamaria, F., Oppenheim, J. J., Lubkowski, J., & Lu, W. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1533186100 · Cited by 439
Self-citationStructure, function, and membrane integration of defensins
White, S. H., Wimley, W. C., & Selsted, M. E. (1995) · Current Opinion in Structural Biology · doi:10.1016/0959-440x(95)80038-7 · Cited by 420
García, J.-R., Jaumann, F., Schulz, S., Krause, A., Rodríguez-Jiménez, J., Forssmann, U., Adermann, K., Klüver, E., Vogelmeier, C., Becker, D., et al. (2001) · Cell and Tissue Research · doi:10.1007/s004410100433 · Cited by 410
Interactions between human defensins and lipid bilayers: Evidence for formation of multimeric pores
Wimley, W. C., Selsted, M. E., & White, S. H. (1994) · Protein Science · doi:10.1002/pro.5560030902 · Cited by 350
Schibli, D. J., Hunter, H. N., Aseyev, V., Starner, T. D., Wiencek, J. M., McCray, P. B., Tack, B. F., & Vogel, H. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108830200 · Cited by 347
Ganz, T. (1999) · Science · doi:10.1126/science.286.5439.420 · Cited by 321
The Structure of Human β-Defensin-2 Shows Evidence of Higher Order Oligomerization
Hoover, D. M., Rajashankar, K. R., Blumenthal, R., Puri, A., Oppenheim, J. J., Chertov, O., & Lubkowski, J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006098200 · Cited by 321
Self-citationCociancich, S., Ghazi, A., Hetru, C., Hoffmann, J. A., & Letellier, L. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)36505-6 · Cited by 319
Yang, D., Chertov, O., & Oppenheim, J. J. (2001) · Journal of Leukocyte Biology · doi:10.1189/jlb.69.5.691 · Cited by 279
Current status of defensins and their role in innate and adaptive immunity
Raj, P. (2002) · FEMS Microbiology Letters · doi:10.1016/s0378-1097(01)00496-7 · Cited by 258
Discovery of new human β-defensins using a genomics-based approach
Peng Jia, H., Schutte, B. C., Schudy, A., Linzmeier, R., Guthmiller, J. M., Johnson, G. K., Tack, B. F., Mitros, J. P., Rosenthal, A., Ganz, T., et al. (2001) · Gene · doi:10.1016/s0378-1119(00)00569-2 · Cited by 251
Broad-spectrum antimicrobial activity of human intestinal defensin 5
Porter, E. M., van Dam, E., Valore, E. V., & Ganz, T. (1997) · Infection and Immunity · doi:10.1128/iai.65.6.2396-2401.1997 · Cited by 224
Defensins promote fusion and lysis of negatively charged membranes
Fujii, G., Eisenberg, D. S., & Selsted, M. E. (1993) · Protein Science · doi:10.1002/pro.5560020813 · Cited by 192
Yeaman, M. R., Bayer, A. S., Koo, S. P., Foss, W., & Sullam, P. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci562 · Cited by 189
Critical Role of Lipid Composition in Membrane Permeabilization by Rabbit Neutrophil Defensins
Hristova, K. A., Selsted, M. E., & White, S. H. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.39.24224 · Cited by 147
Thia Zip Reaction for Synthesis of Large Cyclic Peptides: Mechanisms and Applications
Tam, J. P., Lu, Y., & Yu, Q. (1999) · Journal of the American Chemical Society · doi:10.1021/ja984480u · Cited by 144
Blondelle, S. E., & Lohner, K. (2000) · Biopolymers · doi:10.1002/1097-0282(2000)55:1<74::aid-bip70>3.0.co;2-s · Cited by 139
Neutrophil defensins: Purification, characterization, and antimicrobial testing
Harwig, S. S. L., Ganz, T., & Lehrer, R. I. (1994) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(94)36015-4 · Cited by 133
Thevissen, K., Osborn, R. W., Acland, D. P., & Broekaert, W. F. (2000) · Molecular Plant-Microbe Interactions · doi:10.1094/mpmi.2000.13.1.54 · Cited by 117
Epithelial Defensins Impair Adenoviral Infection: Implication for Adenovirus-Mediated Gene Therapy
Gropp, R., Frye, M., Wagner, T. O. F., & Bargon, J. (1999) · Human Gene Therapy · doi:10.1089/10430349950018355 · Cited by 103
Hristova, K. A., Selsted, M. E., & White, S. H. (1996) · Biochemistry · doi:10.1021/bi961100d · Cited by 85
Starner, T. D., Swords, W. E., Apicella, M. A., & McCray, P. B. (2002) · Infection and Immunity · doi:10.1128/iai.70.9.5287-5289.2002 · Cited by 74
Engineered Salt-insensitive α-Defensins with End-to-end Circularized Structures
Yu, Q., Lehrer, R. I., & Tam, J. P. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.6.3943 · Cited by 69
Human neutrophil peptide defensins induce single strand DNA breaks in target cells
Gera, J., & Lichtenstein, A. K. (1991) · Cellular Immunology · doi:10.1016/0008-8749(91)90136-y · Cited by 68
Mandal, M., Jagannadham, M. V., & Nagaraj, R. (2002) · Peptides · doi:10.1016/s0196-9781(01)00628-3 · Cited by 56
Treponema denticolaIs Resistant to Human β-Defensins
Brissette, C. A., & Lukehart, S. A. (2002) · Infection and Immunity · doi:10.1128/iai.70.7.3982-3984.2002 · Cited by 42
Merlin, D., Yue, G., Lencer, W. I., Selsted, M. E., & Madara, J. (2001) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2001.280.2.c296 · Cited by 31
Cited by
The human beta-defensin-3, an antibacterial peptide with multiple biological functions
Dhople, V., Krukemeyer, A., & Ramamoorthy, A. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.07.007 · Cited by 355
Takahashi, D., Shukla, S. K., Prakash, O., & Zhang, G. (2010) · Biochimie · doi:10.1016/j.biochi.2010.02.023 · Cited by 331
Will new generations of modified antimicrobial peptides improve their potential as pharmaceuticals?
Brogden, N. K., & Brogden, K. A. (2011) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2011.05.004 · Cited by 300
Perspectives for clinical use of engineered human host defense antimicrobial peptides
Pachón-Ibáñez, M. E., Smani, Y., Pachón, J., & Sánchez-Céspedes, J. (2017) · FEMS Microbiology Reviews · doi:10.1093/femsre/fux012 · Cited by 159
Novel lactoferrampin antimicrobial peptides derived from human lactoferrin
HANEY, E., NAZMI, K., LAU, F., BOLSCHER, J., & VOGEL, H. (2009) · Biochimie · doi:10.1016/j.biochi.2008.04.013 · Cited by 81
Metadata
- Authors
- Hoover, D. M., Wu, Z., Tucker, K., Lu, W., & Lubkowski, J.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2003-09
- Volume
- 47
- Issue
- 9
- Pages
- 2804-2809
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2108792803
- Cited by
- 253
- References
- 37
- FWCI
- 5.82
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.